FDA NDC Directory · JSON-LD · Markdown

Acetazolamide

NDC 50742-233 · HUMAN PRESCRIPTION DRUG · CAPSULE, EXTENDED RELEASE

Labeler / ManufacturerIngenus Pharmaceuticals, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA203434
Dosage form / routeCAPSULE, EXTENDED RELEASE · ORAL
Active ingredientsACETAZOLAMIDE (500 mg/1)
Marketing started20170731
Package count1

External sources

Source: openFDA. Public-domain (CC0).